GlaxoSmithKline and CureVac to make Covid vaccines targeting new variants

(Andy Buchanan/PA)

UK-based drug maker GlaxoSmithKline and Germany’s CureVac say they plan to collaborate on a new generation of vaccines targeting emerging variants of Covid-19.

The announcement came as public health experts around the world raise concerns about mutations in the virus that may make existing vaccines less effective.